Atrium Therapeutics, Inc. (RNA)
10.36
-0.15
(-1.43%)
USD |
NASDAQ |
Sep 10, 16:00
10.36
0.00 (0.00%)
After-Hours: 17:10
Atrium Therapeutics Price to Book Value : 0.8259 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 0.8379 |
| September 08, 2026 | 0.9048 |
| September 04, 2026 | 1.131 |
| September 03, 2026 | 1.164 |
| September 02, 2026 | 1.121 |
| September 01, 2026 | 1.098 |
| August 31, 2026 | 1.062 |
| August 28, 2026 | 1.087 |
| August 27, 2026 | 1.114 |
| August 26, 2026 | 1.104 |
| August 25, 2026 | 1.116 |
| August 24, 2026 | 1.086 |
| August 21, 2026 | 1.052 |
| August 20, 2026 | 1.075 |
| August 19, 2026 | 1.093 |
| August 18, 2026 | 1.024 |
| August 17, 2026 | 1.033 |
| August 14, 2026 | 1.024 |
| August 13, 2026 | 0.9829 |
| August 12, 2026 | 0.9702 |
| August 11, 2026 | 0.9782 |
| August 10, 2026 | 0.9758 |
| August 07, 2026 | 0.9837 |
| August 06, 2026 | 0.9654 |
| August 05, 2026 | 0.9359 |
| Date | Value |
|---|---|
| August 04, 2026 | 0.92 |
| August 03, 2026 | 0.9032 |
| July 31, 2026 | 0.9048 |
| July 30, 2026 | 0.9136 |
| July 29, 2026 | 0.8913 |
| July 28, 2026 | 0.916 |
| July 27, 2026 | 0.9224 |
| July 24, 2026 | 0.916 |
| July 23, 2026 | 0.9495 |
| July 22, 2026 | 0.9702 |
| July 21, 2026 | 0.9798 |
| July 20, 2026 | 0.9375 |
| July 17, 2026 | 0.9686 |
| July 16, 2026 | 0.9694 |
| July 15, 2026 | 0.9806 |
| July 14, 2026 | 0.9742 |
| July 13, 2026 | 0.9742 |
| July 10, 2026 | 0.9933 |
| July 09, 2026 | 1.029 |
| July 08, 2026 | 1.066 |
| July 07, 2026 | 1.056 |
| July 06, 2026 | 1.037 |
| July 02, 2026 | 1.088 |
| July 01, 2026 | 1.060 |
| June 30, 2026 | 1.072 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5499 |
| Exicure, Inc. | 8.807 |
| Century Therapeutics, Inc. | 1.504 |
| Absci Corp. | 5.740 |
| Celularity, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.482 |
| PEG Ratio | -0.0071 |
| Price | 10.36 |
| Earnings Yield | -44.48% |
| Market Cap | 177.22M |
| PEGY Ratio | -0.0071 |